Country (ref) | Period | Reported incidences | Comment | Studied variable | |
---|---|---|---|---|---|
perforation | Bleeding | ||||
Norway (18) | 1935–1990 | About 10 | Report birth cohort specific risks for perforation | Admittance rates | |
USA (44) | 1956–1985 | 10-5 | 7-4 | Relatively stable incidence of emergency operations for PUC | Emergency operations |
England and Wales (13) | 1958–1962 1979–1982 | Increasing incidence of PUC* and NSAID use in elderly ♀ | National register | ||
Scotland (13) | 1958–1962 1979–1982 | Increasing incidence of PUC* and NSAID use in elderly ♀ | National register | ||
USA (45) | 1974–1976 1984-1984 | No rate per 100000 inhab | No rate per 100000 inhab | 13% increase in perforations and 7% increase in bleedings after H2-rec blocker introduction | Cases operated |
Poland (11) | 1977–1996 | No rate per 100000 inhab | Constant number/year, increasing % elderly women, increasing mean age | Cases operated | |
Hong-Kong (19) | 1979–1985 | 14–18 | Operating room logbooks | ||
New South Wales (19) | 1979–1985 | 3–4 | Diagnosis reported to dept of heath | ||
Finland (12,46) | 1972–1987 1987–1999 | 4–5 5–7 | 3–4 | Increasingly more ♀, increasing mean age | Cases operated, national register |
Sweden (1) | 1974–92 | 2–11 | Significant decrease in incidence | Patients records | |
Denmark (20) | 1974–1984 | 4–10 | 5–10 | No significant difference before/after H2-receptor blockers | Cases operated |
Finland (17) | 1977–1989 | 2–8 | 3–9 | No significant difference before/after H2-receptor blockers | Cases operated |
Finland (15) | 1979-85-00 | 3-6-4 | No significant difference before/after H2-receptor blockers or PPI | Patients records | |
UK (10) | 1989–99 | ♂ 10–11 ♀ 7-7 | 27–31 14–16 | Admittance rates | |
UK (47) | 1996–98 | ♂ 5 ♀ 4 | Only duodenal perforations, increasing mean age in ♀ | Patients records | |
Germany (23) | 1989–90 1999-00 | 51 49 | Patients older and more NSAID use in the later period | Prospective |